Hers vs Lemonaid Health: Which GLP-1 Provider Is Better?
Short answer: Lemonaid Health scores higher on our rubric, 7.2/10 against 5.3/10. Full reasoning, pricing and the cases where the other one wins are below.
Lemonaid Health beats Hers overall, scoring 7.2/10 vs 5.3/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; Lemonaid Health is published $129/mo; total not verified. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path. Choose Lemonaid Health for users who want a flexible membership with broad medication options, a $49/mo membership plus compounded semaglutide or tirzepatide at $229-299/mo, a $199 compounded microdose, or brand-name zepbound via lillydirect at $299-449.
A side-by-side look at Hers and Lemonaid Health to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hers
#44 of 54The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. Wegovy and Foundayo carry FDA approval for weight management. Ozempic is FDA approved for type 2 diabetes and is prescribed off label for weight loss. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.
Visit HersLemonaid Health
#32 of 54Telehealth platform operating since 2013, restructured in 2026 to a $49/mo Weight Loss Membership with medication billed separately. The menu runs compounded semaglutide and tirzepatide, compounded microdoses at $199/mo, brand-name Zepbound through LillyDirect at $299-449, plus cash-price Wegovy and Ozempic. Weight loss is not offered in every state and Lemonaid does not publish the list.
Visit Lemonaid Health| Feature | Hers | Lemonaid Health |
|---|---|---|
| Why each one | A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. | One of the oldest and most established telehealth brands in the GLP-1 space, over a decade of operation and physician-only prescribing standards that exceed most competitors. |
| Our Score | 5.3/10 | 7.2/10 |
| Headline Price | $188 first month, then $298/mo | published $129/mo; total not verified |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path | Users who want a flexible membership with broad medication options, a $49/mo membership plus compounded semaglutide or tirzepatide at $229-299/mo, a $199 compounded microdose, or brand-name Zepbound via LillyDirect at $299-449 |
| Watch out for | Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03). | Membership and medication billed separately, the $49/mo number is just the membership, not all-in |
| Ranking | #44 | #32 |
| Get started | Visit Hers | Visit Lemonaid Health |
Pros & Cons Compared
Hers
Pros
- +Brand-name paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199. Wegovy and Foundayo carry FDA approval for weight management, Ozempic is approved for type 2 diabetes and is used off label here. With the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
Lemonaid Health
Pros
- +2026 restructure, $49/mo Weight Loss Membership (replaces the old $25/visit model)
- +6-month plan discount, compounded tirzepatide drops to $229/mo on a 6-month commitment
- +Wide medication menu: compounded sema, compounded tirz, compounded microdoses ($199), brand-name Zepbound via LillyDirect ($299-449), and metformin
- +Operating since 2013, one of the longer running telehealth brands prescribing GLP-1s
Cons
- −Membership and medication billed separately, the $49/mo number is just the membership, not all-in
- −Brand-name Wegovy ($1,599) and Ozempic ($1,199) cash prices are high, read as access, not value
- −Best compounded pricing requires a 6-month commitment and only tirzepatide has one, semaglutide has no 6-month tier
- −Fees paid are non-refundable, cancelling needs 48 hours notice before a renewal, and a started 3 or 6 month plan is billed to the end of its term
Our Verdict
Lemonaid Health edges out Hers with a score of 7.2/10 vs 5.3/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; Lemonaid Health is published $129/mo; total not verified.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Hers and Lemonaid Health.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Compare Hers and Galafrom $149/mo
- Compare Hers and Wellorithmfrom $147/mo
- Compare Hers and Mochi Healthfrom $139/mo
- Compare Lemonaid Health and MEDVi$179 first month, then $299/mo
- Compare Lemonaid Health and SynergyRxfrom $199/mo
- Compare Lemonaid Health and Oak Longevityfrom $167/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Hers legit and is Lemonaid Health legit, with the verification evidence behind each answer.
Our pick of these two: Lemonaid Health · 7.2/10